drugset / Trial / NCT01142050
Stem Cell Therapy for Type 2 Diabetes Mellitus
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the efficacy and safety in the treatment of Insulin Resistance of Type 2 Diabetes Mellitus with Bone Marrow Mesenchymal Stem Cells.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-08
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | — | Other |